home / stock / qsam / qsam news

QSAM News and Press, QSAM Biosciences Inc From 11/14/23

Stock Information
Company Name: QSAM Biosciences Inc
Stock Symbol: QSAM
Market: OTC
Website: qsambio.com
Menu
QSAM QSAM Quote QSAM Short QSAM News QSAM Articles QSAM Message Board
Get QSAM Alerts

News, Short Squeeze, Breakout and More Instantly...
QSAM - QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee

Austin, TX, Nov. 14, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing therapeutic radiopharmaceuticals for the treatment of primary and secondary bone cancer and related conditions, has signed a non-binding term sheet (the “Term Sheet”) with Tel...
QSAM - InvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Issues Update on Progress, Preliminary Clinical Data for Phase 1 CycloSam(R) Trial

QSAM Biosciences (OTCQB: QSAM) , a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (“CycloSam(R)”), for the treatment of bone cancer and related diseases, today issued a letter to its shareholders. In the letter, the company’s...

QSAM - QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data

AUSTIN, Texas, Aug. 16, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam ® ), for the treatment of bone cancer and related diseases, today issued the followi...

QSAM - InvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Adds UT-Austin to Supply Chain, Expanding Capacity for CycloSam(R) Production

QSAM Biosciences (OTCQB: QSAM) is a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals for the treatment of cancer and other diseases and conditions. The company today announced the qualification and addition of the nuclear reactor at the University ...
QSAM - QSAM Biosciences Adds the Nuclear Reactor at the University of Texas at Austin to its Radioisotope Production Supply Chain for its Bone Cancer Treatment Drug Candidate, CycloSam®

Austin, TX, June 14, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals for the treatment of cancer and other diseases and conditions, announced today the qualification and addi...

QSAM - InvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Adds Clinical Trial Site for CycloSam(R) Study

QSAM Biosciences (OTCQB: QSAM) , a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam), for the treatment of bone cancer and other diseases and conditions, has added a site for its phase 1 study. The company ann...

QSAM - QSAM Biosciences Expands its Study of CycloSam® in the Treatment of Bone Cancer; Opens Patient Enrollment at Key Chicago Center, Insight Hospital and Medical Center

Austin, TX, May 23, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam ® ), for the treatment of bone cancer and other diseases and conditions, today announces the...
QSAM - InvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Inks Supply Agreement with Leading Nuclear Medicine Pharmacy Network

QSAM Biosciences (OTCQB: QSAM) , a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, has announced a partnership with RLS (USA) Inc., the third-largest nuclear medicine pharmacy network in the country. The two companies have a commercial s...

QSAM - QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam®

Partnership is Latest in Series of RLS Effort s to Expand Industry-Leading CDMO Business and Clinical Trial Capability with Radiopharmaceutical Partners Across U.S. Austin, TX and Lake Zurich, IL, May 16, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc...

QSAM - QSAM Biosciences receives patent in Europe for bone cancer treatment

2023-04-26 08:56:34 ET QSAM Biosciences ( OTCQB:QSAM ) announced the reception of a second patent from the European Patent Office. The patent safeguards the use of "lower specific activity" Samarium-153 when treating bone cancer in children and adults. This new patent in Europe co...
Previous 10 Next 10